2m 2m 2m 2m 2m 2m 2m
SI-BONE (SIBN)
NASDAQ
$13.92-$0.09 (-0.64%)
Price as of Jun 03, 2026 6:21 PM EDT- $625.3MMarket Cap
- -25.87%1-Year Change
- Medical DevicesIndustry
SI-BONE (SIBN)
$13.92-$0.09 (-0.64%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 200.9M +20.19% | 167.2M +20.37% | 138.9M +30.52% | 106.4M +18.03% | |
Cost of Revenue | 41.0M +17.08% | 35.1M +18.97% | 29.5M +87.62% | 15.7M +50.60% | |
Gross Profit | 159.9M +21.01% | 132.1M +20.75% | 109.4M +20.63% | 90.7M +13.77% | |
Sales and Marketing Expense | 124.2M +6.13% | 117.1M +6.17% | 110.3M +2.35% | 107.7M +14.74% | |
Research and Development Expense | -17.4M +5.36% | -16.6M +10.19% | -15.0M +10.28% | -13.6M +9.53% | |
Depreciation and Amortization Expense | 5.8M +31.77% | 4.4M -19.33% | 5.4M +57.24% | 3.5M +65.48% | |
Total Operating Expenses | 182.2M +8.87% | 167.4M +7.05% | 156.4M +4.02% | 150.3M +14.40% | |
Operating Profit | -22.3M -36.65% | -35.2M -24.89% | -46.9M -21.27% | -59.6M +15.36% | |
Interest Income | 6.1M -22.60% | 7.8M +13.48% | 6.9M +430.37% | 1.3M +601.08% | |
Interest Expense | N/A N/A | N/A N/A | -3.5M +22.81% | -2.8M -47.46% | |
Interest Income and Expense and Net | 6.1M -22.60% | 7.8M +127.21% | 3.5M +327.99% | -1.5M -70.75% | |
Total Nonoperating Income and Expense | -20,000 -72.60% | -73,000 -151.77% | 141,000 +206.82% | -132,000 -147.65% | |
Income before Taxes | -22.3M -36.65% | -35.2M -24.89% | -46.9M -21.27% | -59.6M +15.36% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -18.9M -38.85% | -30.9M -28.67% | -43.3M -29.25% | -61.3M +8.28% | |
Net Income from Continuing Operations Applicable to Common | -18.9M -38.85% | -30.9M -28.67% | -43.3M -29.25% | -61.3M +8.28% | |
Basic EPS and Net Income | -0.44 -41.33% | -0.75 -33.63% | -1.13 -36.87% | -1.79 +4.68% | |
Diluted EPS and Net Income | -0.44 -41.33% | -0.75 -33.63% | -1.13 -36.87% | -1.79 +4.68% | |
Basic Weighted Average Shares | 43.0M +3.60% | 41.5M +7.91% | 38.4M +12.35% | 34.2M +3.19% | |
Diluted Weighted Average Shares | 43.0M +3.60% | 41.5M +7.91% | 38.4M +12.35% | 34.2M +3.19% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 42.2M +20.87% | 34.9M +5.04% | 33.3M +60.60% | 20.7M -67.33% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 76.6M -8.36% | |
Cash and Cash Equivalents and Short-Term Investments | 42.2M +20.87% | 34.9M +5.04% | 33.3M -65.80% | 97.3M -33.81% | |
Total Current Assets | 216.1M +4.01% | 207.8M -1.71% | 211.4M +53.62% | 137.6M -21.75% | |
Accumulated Depreciation | 22.5M +15.38% | 19.5M +28.17% | 15.2M +49.37% | 10.2M +46.53% | |
Property and Plant and Equipment and Net | 21.3M +4.54% | 20.4M +27.34% | 16.0M +2.80% | 15.6M +73.09% | |
Total Long-Term Assets | 55,000 -81.67% | 300,000 -7.69% | 325,000 -13.33% | 375,000 -6.25% | |
Total Assets | 238.6M +3.52% | 230.4M +0.005% | 230.4M +46.25% | 157.6M -17.30% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 100,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 25.3M -6.83% | 27.1M +15.67% | 23.5M +10.76% | 21.2M +25.39% | |
Total Long-Term Debt | 35.6M +0.33% | 35.5M -1.70% | 36.1M +2.54% | 35.2M +0.57% | |
Total Long-Term Liabilities | 0 -100.00% | 10,000 -44.44% | 18,000 -40.00% | 30,000 -47.37% | |
Total Liabilities | 61.0M -3.86% | 63.5M +3.97% | 61.0M +3.04% | 59.3M +5.64% | |
Retained Earnings | -450.3M +4.38% | -431.4M +7.72% | -400.4M +12.14% | -357.1M +20.71% | |
Total Stockholders Equity | 177.5M +6.33% | 167.0M -1.42% | 169.4M +72.30% | 98.3M -26.87% | |
Total Shares Outstanding | 43.6M +3.71% | 42.1M +3.42% | 40.7M +17.17% | 34.7M +3.14% | |
Cash Flow | |||||
Cash from Operating Activities | -675,000 -94.57% | -12.4M -33.60% | -18.7M -55.08% | -41.7M +5.37% | |
Capital Expenditures | 8.4M -19.84% | 10.5M +34.59% | 7.8M -17.97% | 9.5M +48.80% | |
Cash from Investing Activities | 4.2M -67.04% | 12.6M +121.11% | -59.8M +2,024.26% | -2.8M -105.46% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.4M +72.42% | 2.0M -97.85% | 90.9M +4,038.96% | 2.2M +228.40% | |
Financials Ratio | |||||
Gross Margin | 79.57% +0.69% | 79.03% +0.31% | 78.78% -7.57% | 85.24% -3.61% | |
Operating Margin | -11.11% -47.29% | -21.08% -37.60% | -33.79% -39.68% | -56.02% -2.26% | |
Return on Assets | -8.06% -39.91% | -13.42% -39.95% | -22.34% -36.53% | -35.20% +28.68% | |
Return on Equity | -10.97% -40.30% | -18.38% -43.23% | -32.38% -38.49% | -52.64% +41.34% | |
Revenue Growth | 20.19% -0.91% | 20.37% -33.26% | 30.52% +69.25% | 18.03% -21.06% | |
Current Ratio | 8.55 +11.64% | 7.66 -15.03% | 9.01 +38.70% | 6.50 -37.60% | |
Cash Ratio | 1.67 +29.73% | 1.29 -9.19% | 1.42 +45.00% | 0.98 -73.95% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow